Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Manning Meredith Insider Profile
4 Followers
Manning Meredith, CCO at Adicet Bio, holds ― shares in Adicet Bio (Ticker: ACET), holds 53.60K shares in Soleno Therapeutics (Ticker: SLNO). Most recently, Manning Meredith ― shares of Adicet Bio on ― for an estimated value of ―.
Manning Meredith has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Manning Meredith
Manning Meredith's Trading History
Adicet Bio
―
CCO
―
―
Soleno Therapeutics
Jan 23, 2025
CCO
Uninformative Buy
―
$2.47M
List of latest transactions for each holding click on a transaction to see Manning Meredith's performance on stock
You May Also Like
Manning Meredith insider profile FAQ
What is the percentage of profitable transactions made by Manning Meredith?
The percentage of profitable transactions made by Manning Meredith is ―.
What is the average return per transaction made by Manning Meredith?
The average return per transaction made by Manning Meredith is ―.
What stocks does Manning Meredith hold?
Manning Meredith holds: ACET, SLNO stocks.
What was Manning Meredith’s latest transaction?
Manning Meredith latest transaction was an Uninformative Buy of ―.
What was Manning Meredith's most profitable transaction?
Manning Meredith’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Manning Meredith's role in Adicet Bio?
Manning Meredith's role in Adicet Bio is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.